Apricus Biosciences, Inc. ‘s APRI shares gained 7.7% after the company announced that it has entered into a license agreement with Allergan AGN under which it will regain the U.S. development and commercialization rights to Vitaros from the latter.
Apricus Up after Regaining Vitaros U.S. Rights from Allergan
